(1)
A Prospective Study of Clinical Profile of Type 2 Lepra-Reaction, Clinical Responses to Treatment With Thalidomide and Seroprevalence of HIV in Reactional Patients. J Pak Assoc Dermatol 2024, 34 (4), 967-972. https://doi.org/10.66344/jpad.v34i4.2717.